topic stringlengths 245 1.29k | doc stringlengths 52 16.9k | label stringclasses 3
values |
|---|---|---|
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Non-Hodgkin's Lymphoma Follicular Lymphoma Diffuse Large Cell Lymphoma Mantle Cell Lymphoma Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia SLL / CLL 1. Diagnosis of B-cell SLL/ CLL including Lymphocytosis of monoclonal B-cells co-expressing ≥ one B-cell marker (CD19, CD20, o... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 10.0-999.0, Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma in first or subsequent relapse or with primary refractory disease in whom the EBV-genome or antigens have been demonstrated in tissue biopsy samples Age 10 years or older Life expectancy of 8 weeks or more Karnofsky or Lansky score of... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Indolent Lymphoma Need for therapy in patients with relapsed/refractory patients Histological proven diagnosis of an indolent B-cell lymphoma according to the World Health Organization (WHO) classification belonging to one of the following entities follicular lymphoma mantle cell lym... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-35.0, High Risk Solid Tumors Recurrent Solid Tumors Patients diagnosed with high risk recurrent or refractory solid tumors following initial chemotherapy 2. Tumor must be sensitive to chemotherapy (maximum 8 cycles) and/or radiation defined as a greater than 50% reduction in size of the prim... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Non-Hodgkin's Lymphoma Age ≥ 18 years Biopsy proven intermediate grade NHL No previous chemotherapy At least 4 courses of R-CHOP at maximal doses are planned An informed consent Do not meet all | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma Histologically confirmed CD20-positive diffuse large B-cell non-Hodgkin lymphoma (DLBCL) according to the current WHO classification, including all morphological variants Newly diagnosed disease Bulky stage IA-IV disease No non-bulky stage IA disease Measurable disease Not e... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Inflammation Necrosis Healthy children (ASA PS 1) Children presenting one or more primary molar with pulp inflammation or necrosis due to carious lesion and indicated for endodontic therapy Lost to follow-up | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 65.0-999.0, Chronic Lymphocytic Leukemia Diagnosis of chronic lymphocytic leukemia (CLL) meeting the following Minimum threshold peripheral lymphocyte count of 5 x 10^9/L (CLL variant) OR palpable adenopathy > 1 cm or palpable splenomegaly 9small lymphocytic lymphoma [SLL] variant) Immunophenoty... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-55.0, Musculoskeletal Pain Signed and dated informed consent prior to participation Subjects in good health as determined by the Investigator Age 18-55 Willing to abstain from any physical therapy, hard physical work, exercise or sauna during the study observation period (Screening to Final... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, HIV Infection Liver Failure Evidence of Liver Transplantation Age ≥ 18 Documented HIV-1 infection, hepatitis B or C co-infection is allowed Plasma viral load at screening visit below 50 copies per mL for at least 6 months Patient with severe liver failure (Meld Score ≥ 15 and/or refr... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.5-999.0, HIV Infection Rheumatic Disease Cancer Transplant Pediatrics medically recommended influenza A(H1N1) immunization signed informed consent failure or refusal to provide sufficient blood for antibody determination | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-59.0, First Episode Psychosis Aged 18-59 years and meet DSM-IV diagnostic for first episode of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder NOS as assessed by using the Structured Clinical Interview for DSM-IV, research version Meeting DSM-IV for... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Metastatic Melanoma ENTRY Locally advanced or metastatic melanoma Measurable Histologically or cytologically confirmed Surgically incurable HLA-A2 positive and tumors that present HLA-A2.1/p53aa264-272 complexes PRIOR/CONCURRENT If prior Proleukin treatment, must have had clinical be... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Previously treated orrefractory classical large B-cell lymphomas, Grey-zone lymphoma and Hodgkin lymphoma, including Lymphocyte predominant Hodgkin Lymphoma (LPHL). 2. Confirmed pathological diagnosis by the Laboratory of Pathology, NCI.... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Ovarian Cancer Non Small Cell Lung Cancer Prostate Cancer Colorectal Cancer Gastric Cancer Esophageal Cancer Cancer of Head and Neck Diagnosis of ovarian, non-small cell lung, prostate, colorectal, gastroesophageal cancer (adenocarcinoma of the esophageal cancer, stomach, or gastroes... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Clinical diagnosis with CLL Clinical decision made to initiate first-line therapy, second-line therapy or subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but within 2 months of enrollment Age≥18 years Willing and able to pr... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Asthma Patients who have given their informed consent and expressed interest in participating in the study Asthmatic Patients Patients with communication difficulties Persons who obtain symbicort but not for their own use Patients with other major diseases: Heart problems, COPD, lun... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hairy Cell Leukemia (HCL) Chronic Lymphocytic Leukemia (CLL) Non-Hodgkins Lymphoma (NHL) Cutaneous T Cell Lymphoma (CTCL) Adult T Cell Lymphoma (ATL) Patients may have a diagnosis of hematologic malignancy, including HCL, CLL, CTCL, ATL, NHL, ALL, or solid tumor, including mesothelio... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Cystic Fibrosis Gender: Male or female (non-pregnant, non-lactating) Cystic fibrosis documented by a compatible clinical and radiographic presentation, and sweat chloride > 60 mEq/l or 2 disease causing CFTR mutations Severity of Disease: 1. Must have FEV1 of greater than or equal to... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Non Hodgkin's Lymphoma NHL Aggressive NHL Diffuse Large B-cell Lymphoma Male or female, >18 years old Histological diagnosis of CD20+ B-cell NHL, with DLBCL or other aggressive lymphomas by WHO lymphoma including mantle cell lymphoma and transformed follicular lymphoma Failed at leas... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, Hepatic Encephalopathy Patients diagnosed as having cirrhosis of liver at the Inpatient/Outpatient Liver Clinic of Department of Hepatology, Chandigarh, will be candidates for enrollment The diagnosis of cirrhosis of liver will be based on clinical, biochemical, and ultrasonographical... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Must be 18 years of age Must meet the clinical and laboratory for B-CLL (i.e., compatible clinical history and physical exam, presence of lymphocytosis, i.e., >10,000 lymphocytes / mm3, evidence for a monoclonal population of CD5+/CD19+/CD23+ cells in the... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-99.0, Lymphoma, Mantle-cell CLL (Chronic Lymphocytic Leukemia) Monoclonal B-Cell Lymphocytosis Healthy Volunteers Small Lymphocytic Lymphoma (MBL, CLL/SLL, MCL group) 4.1.1.<TAB>Diagnosed with MBL, CLL/SLL, or MCL 4.1.2.<TAB>Greater than or equal to 18 years of age 4.1.3.<TAB>Neutrophil cou... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Mediastinal Lymphadenopathy Tuberculous Mediastinal Lymphadenopathy All patients with mediastinal lymphadenopathy of unknown etiology 2. All patients signed informed consent before the procedure Age less than 18 years 2. Bleeding diathesis (INR>1.4 or platelet count<10k/mcl) | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 10.0-83.0, Lymphadenopathy Patients with previously untreated neck masses underwent neck US The neck mass was not lymph node No US-FNA cytology result | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.5-75.0, Lymphoma Leukemia Myelodysplastic Syndrome First-degree related donor who is at minimum HLA haploidentical Eligible diagnoses: 1. Low-grade non-Hodgkin's lymphoma or plasma cell neoplasm that has progressed during multiagent therapy, failed at least two prior therapies (excluding singl... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Symptomatic Waldenstroms Macroglobulinaemia At least 18 years of age Diagnosis of WM histologically confirmed on bone marrow biopsy Detectable IgM paraprotein >5 g/L Less than 3 lines of prior therapy for WM Full blood count within 4 weeks prior to screening shows ANC >1.0 x109/l AND... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-99.0, Small Lymphocytic Lymphoma CLL (Chronic Lymphocytic Leukemia) Histologically confirmed CLL or SLL as defined by the following B-lymphocytosis greater than 5000 cells/micro L (may be less than 5000 cells/micro L if lymphadenopathy is present with histologic confirmation of lymph node i... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Healthy Is the individual a healthy, normal adult man or non-child bearing potential woman who volunteers to participate? Is s/he at least 18 years of age? Is his/her BMI between 19 and 30, inclusive? Is s/he considered reliable and capable of understanding his/her responsibility and... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Healthy Is the individual a healthy, normal adult man or non-child bearing potential woman who volunteers to participate? Is s/he at least 18 years of age? Is his/her BMI between 19 and 30, inclusive? Is s/he considered reliable and capable of understanding his/her responsibility and... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Richter's Syndrome Signed written informed consent prior to performing any study-specific procedures Patients with B-CLL and newly diagnosed not previously treated and biopsy proven DLBCL Richter's transformation Computerized tomography (CT) scan performed within 6 weeks prior to sta... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-99.0, Hepatitis C HIV A subject must satisfy all of the following to be eligible to participate in this study: 1. Latino ethnicity. Latino ethnic background will be defined as a geographic, historical, and cultural heritage shared among persons from Spanish-speaking countries in South and C... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Arthroplasty, Knee Replacement Replacement, Total Knee Total Knee Replacement Scheduled to undergo primary total knee arthroplasty Age 18 or over Inability to provide informed consent or to comply with study assessments due to cognitive impairment or geographic distance Age 17 or yo... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 65.0-999.0, Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL) Key Histologically or cytologically confirmed CLL or SLL Age ≥ 65 Presence of measurable lymphadenopathy (defined as the presence of ≥1 nodal lesion that measures ≥ 1.5 cm in the longest diameter (LD) and ≥ 1.0 cm in... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 2.0-999.0, Leukemia Adult and pediatric (=/> 2 years old) patients with a diagnosis of acute myelogenous leukemia (including undifferentiated and bi-phenotypic leukemia), or high-risk myelodysplastic syndrome, or chronic myelogenous leukemia in blast crisis who will receive first or second anti-... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, B-cell Chronic Lymphocytic Leukemia Hematopoietic/Lymphoid Cancer Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Previously treated patients with a diagnosis of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL),... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-85.0, Mediastinal or Intra-abdominal Lymphadenopathy, Pancreatic Masses, Left Adrenal Masses, Gastrointestinal Submucosal Lesions, and Liver Masses Age greater than 18 years Presence of mediastinal or intra-abdominal lymphadenopathy, solid pancreatic mass, left adrenal mass, gastrointestina... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, B-cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Prolymphocyctic Leukemia Richter's Transformation Subjects with histologically confirmed chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), prolymphocytic leukemia (PLL), or Richter's transformation ari... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 13.0-85.0, Myelodysplastic Syndrome (MDS) Aplastic Anaemia (AA) Myelofibrosis (MF) Thalassemia Intermedia A diagnosis of MDS, AA, MF or thal based on currently recognized diagnostic criteria. 2. Explored or undergone established therapies eg haemopoietic stem cell transplant, immunosuppressive t... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 65.0-999.0, Lymphocytic Leukemia, Chronic Adult patients, >/= 65 years of age Previously untreated B-cell chronic lymphocytic leukemia (CLL) Binet stage C or active Binet stage A and B disease Prior treatment for CLL CLL with transformation (Richter's syndrome) Suspected or known central nervou... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hepatitis C Male or female patients of minimum adult legal age (according to local laws for signing the informed consent document), able to provide written informed consent, and understand and comply with the requirements of the study 2. HCV genotype 1 infected null responders to pri... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Colorectal Cancer Patients with the diagnosis of metastatic colorectal cancer, either newly diagnosed or recurrent, with measurable disease that has not been irradiated within the last 5 weeks Age > 18 years old ECOG performance status 0-3 Patients who have received prior therapy in... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, B-cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Histologically confirmed CLL or SLL and satisfying at least 1 of the following for requiring treatment Progressive splenomegaly and/or lymphadenopathy identified by physical examination or radiographic studies Anemia (<11... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia B-cell Chronic Lymphocytic Leukemia (CLL) Patients must have intermediate or high-risk categories of the modified 3-stage Rai and Binet staging Patient MUST have progressive or symptomatic disease as defined by any of the following conditions Progressive ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Cytopenias Erythropenia (Diagnosis) Use of linezolid is not less than 3 days Serious adverse reactions | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 12.0-999.0, Leishmaniasis Cutaneous Leishmaniasis Gender: Male or female Age: >12 yrs of age Clinicla presentation: 1-2 ulcerative lesions, each < 30 mm in largest diameter, and with a total lesion area <900 mm2 Parasitological confirmation of the lesion will be made by visualization or culture ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-75.0, Myelodysplastic Syndrome MDS defined according to WHO classification (also including RAEB-T according to FAB classification) (see appendix 1) with intermediate-2 or high risk IPSS (see appendix 1) Age ≥ 18 years and <75 years Must understand and voluntarily sign an informed consent fo... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Leukaemia Adults with documented diagnosis of active CLL requiring treatment Bulky lymphadenopathy, defined as at least 1 lymph node >5 cm Must be refractory to fludarabine treatment Age 18 yrs or older At least 2 prior therapies for CLL Eastern Cooperative Oncology Group (ECOG) perf... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-99.0, Chronic Myelogenous Leukemia Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Individuals who are candidates for allotransplant therapy for hematologic malignancies and are being evaluated at the Clinical Center for planned allotransplant... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-65.0, Hodgkin Lymphoma Age range: 18-65 years old Histological confirmed refractory or relapsed Hodgkin lymphoma With at least one site of measurable disease according to IWC ECOG performance status 0-1 Life expectancy of more than 3 months Bone marrow function: ANC≧1.5×109/L, PLT≧100×109/L... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Chronic Lymphocytic Leukemia diagnosis of CLL at least two available stored samples at least one criterium not fulfilled | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma Male or Female, aged ≥ 18 yrs ECOG performance score of 0, 1 or 2 Life expectancy of at least 12 weeks Haematological and biochemical indices within the ranges shown below Lab Test Value required Haemoglobin (Hb) ≥ 9g/dL White Blood Count (WBC) ≥ 2x109/L Platelet count ≥ 100... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Mediastinal Lymphadenopathy Age older than 18 years 2. Patient with suspected malignant mediastinal lymphadenopathy Age younger than 18 years 2. Bleeding diathesis(INR > 1.4, Platelet count < 10,000/mcl) | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 12.0-75.0, Cutaneous Leishmaniasis Parasitological confirmation at least 1 lesion must be ulcerative No specific antileishmanial therapy during the previous six months Concomitant diseases such as Tuberculosis, HIV, diabetes, renal failure, liver disease abnormalities CTC 2 in blood, liver, kid... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 12.0-999.0, Cutaneous Leishmaniasis Gender: Male or female Age: >12 yrs of age Presentation: At least 1 lesion must be ulcerative. No more than 3 lesions. Parasitology: Parasitological confirmation of 1 lesion will be made by visualization or culture of leishmania from the biopsy or aspirate of ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Thrombocytopenia Confirmed diagnosis of CLL (based immunophenotyping performed at the central reference laboratory of the in Cologne) Platelet count <50 000/μl at time of screening (measured and confirmed twice) Patient is planned to receive alkylating ag... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 15.0-85.0, CLL Patients with CLL and lymphocyte count > 10 x 109/l Acute infection | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphocytic Leukemia, Chronic Confirmed diagnosis of CD20-positive B-cell CLL (per International Workshop on Chronic Lymphocytic Leukemia [IWCLL] guidelines) Rai Stage III/IV or Binet Stage C disease, or Rai Stage I/II or Binet Stage B disease that requires treatment according to IWC... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Pancreatic Cancer years of age or older Diagnosis of metastatic pancreatic cancer; subjects must have had measurable, or evaluable disease that was histologically confirmed Karnofsky performance status of ≥ 60 Subjects must have failed 1st-line gemcitabine treatment for metastatic pa... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma Histologically confirmed OAML Non-conjunctival or bilateral conjunctival (TNM-based, above T1N0M0 or bT1N0M0), Ann Arbor stage I and II OAML Previously untreated Age ≥18 years Performance status: ECOG 0-2 Adequate hematological function: hemoglobin ≥9 g/dL,, absolute neutrop... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukaemia Small Lymphocytic Lymphoma Aged ≥ 18 years Patients affected by CLL / SLL Presence of active disease defined as the presence of one of the following: Disease related symptoms (weight loss >10% in the last 6 months, fever >38° C for 2 weeks without eviden... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Leukaemia, Lymphocytic, Chronic All CLL patients who have previously received Arzerra, whether alive or deceased Patients who have either completed the full course of Arzerra therapy or discontinued treatment early CLL patients newly initiating Arzerra Patients having been treated wi... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, CLL SLL Documented CLL/SLL deletion by FISH in 20% or more nuclei on peripheral blood, bone marrow or lymph node Normal organ function Pregnant or breast feeding Current active hepatic or biliary disease Chronic or current infectious disease requiring systemic antibiotics, antifunga... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Leukemia Leukemia, Lymphocytyc CLL (Chronic Lymphocytic Leukemia) SLL (Small Lymphocytic Lymphoma) Cohort 1: Treated and untreated patients age 65 or older and need for therapy Cohort 2: Treated (maximum accrual n=16) and untreated (n=27, evaluable) patients at least 18 years old wit... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-45.0, Healthy Is the individual a healthy, normal adult man or woman who volunteers to participate? Is s/he within 18 to 45 years of age, inclusive? Is his/her BMI between 19 and 30 inclusive? Is she willing to avoid pregnancy by abstaining from sexual intercourse with a non-sterile male pa... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Patients must have histologically confirmed B-cell chronic lymphocytic leukemia (B-CLL)/small lymphocytic lymphoma (SLL) or a B-cell prolymphocytic leukem... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 7.0-100.0, Eosinophilia Hypereosinophilic Syndrome Leukocyte Disorder Hematologic Diseases Subjects on Protocol #94-I-0079 will be eligible for participation in the study only if all of the following apply: 1. Subjects must be 7 years of age or older to enroll 2. Subject meets diagnostic for HES... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Waldenström Macroglobulinemia Diagnosis of Waldenstrom Macroglobulinemia and presence of cluster of differentiation (CD)20+ tumor cells as determined by immune-histochemistry or flow cytometric analysis in bone marrow or representative lymphoid tissue specimen; to be deemed eligible,... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Adult subjects with previously treated recurrent CLL who have measurable lymphadenopathy Require therapy for CLL Have experienced CLL progression < 24 months since the completion of the last prior therapy Currently not sufficiently fit to receive cytotoxi... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-65.0, Fibromyalgia In order to qualify the subject: 1. must have been diagnosed with fibromyalgia by a medical doctor 2. must be between the ages of 18 to 65 years of age 3. must have a weekly overall body pain average score ≥ 4 4. must pass a screening questionnaire that calculates a physi... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-999.0, Hodgkin's Disease Non-Hodgkin's Lymphoma Lymphoproliferative Disease Lymphoma at time of Procurement 1. Any patient, regardless of age or sex, with EBV-positive Hodgkin's or non-Hodgkin's Lymphoma, (regardless of the histological subtype) or EBV (associated)-T/NK-lymphoproliferative d... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, B-Cell Chronic Lymphocytic Leukemia The diagnosis of CD20 positive chronic B lymphocytic leukemia (BCLL) confirmed by biopsy or flow-cytometry Previously treated patients with stage Rai I-IV and progressive disease (according to IWCLL 2008 guidelines). Active B-CLL is defined by at l... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-79.0, Lymphoma, Follicular Lymphoma, Non-Hodgkin Multiple Myleoma Lympocytic, Follicular Leukemia Hodgkin Lymphoma Eligible cases will be patients at a participating hospital who are between 18 and 79 years of age at time of initial diagnosis and admitted or treated with incident diagnoses ... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Waldenstrom's Macroglobulinaemia Age ≥ 18 years Confirmed diagnosis of WM (according to consensus panel / WHO criteria) with measurable IgM paraprotein Previously untreated disease at any stage requiring therapy at the discretion of the treating physician. Suggested for initiating tr... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-64.0, HIV Dementia Men and women 18 years of age or older and less than 65 years of age. Able to read and understand English. HIV infected on stable ART regimen for 5 months or greater, and not likely to change regimen for the duration of the study. Significant dementia but able to give con... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-80.0, Erectile Dysfunction Incomplete response to active treatment (not placebo) on first round but patient is still unsatisfied. 2. Recurring ED (had improved on first round of shock wave therapy but after a certain period of time became clinically worse again) after shock wave therapy. 3.... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-75.0, B-cell Chronic Lymphocytic Leukemia FOR BLAST (procurement) Patients with B-CLL (not in Richter's transformation) with measurable disease Procurement consent signed and faxed to Research Coordinator HIV negative (can be pending at this time) FOR AND (protocol entry) Manipulated B-CLL ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoma Adult patients >18 years of age CD20+ low-grade (indolent) lymphoma of follicular and marginal zone type, small lymphocytic lymphoma without a B-CLL phenotype, or indolent lymphoma not otherwise specified Stage II (with bulky disease), III, or IV lymphoma No previous chemoth... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that meets protocol-defined Active disease meeting at least 1 of the International Workshop on Chronic Lymphocytic Leukemia 2008 for requiring t... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 20.0-74.0, Diabetes, Type 2 Patients who completed Study 262-09-001 (namely, patients who visited the hospital at visit Week 24） Patients who are capable of giving informed consent prior to participating in this clinical study Patients who are able to take contraceptive measures to avoid pregnan... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia Key Adults with previously treated recurrent CLL who have measurable lymphadenopathy Require therapy for CLL Have experienced CLL progression < 24 months since the completion of the last prior therapy Have disease that is not refractory to ofatumumab Note... | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Anemia Hematopoietic/Lymphoid Cancer Lymphopenia Neutropenia Thrombocytopenia No evidence of active disease as measured by staging studies pertinent to the particular diagnosis within 1 month of the CD 34+ boost 2. Full donor chimerism as manifested by a ≥ 90% donor peripheral blood ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Superficial Bladder Cancer Aged 18 years or older at the time of consent 2. Able to give informed consent 3. Subjects with high grade BCG-refractory or relapsed NMIBC including High grade non-invasive papillary carcinomas (Ta) and subjects with high grade tumors that invade sub-epith... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 19.0-60.0, Chronic Fatigue Syndrome Males and females 19-60 years old Hemoglobin concentration between 13 and 14 g/dL(men), 12 and 13 g/dL(women) Able to give informed consent Allergic or hypersensitive to any of the ingredients in the test products History of reaction to any of the test produc... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Lymphoid Malignancies Previously treated recurrent B-cell iNHL, DLBCL, MCL, HL or CLL Measurable lymphadenopathy Requires therapy Recent history of a major non-lymphoid malignancy Evidence of ongoing infection Concurrent participation in another therapeutic clinical trial | 2 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, Cirrhosis of Liver Hepatic Encephalopathy Hepatic cirrhosis based on clinical, biochemical, radiological and/or histological data Patients with overt acute grade 2, 3 and 4 HE, according to the West Haven with or without precipitating factors Age of patient 18-70 years Patients who a... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Chronic Lymphocytic Leukemia (CLL) Patients must have diagnosis of CLL (as defined by the NCI below Patients must have peripheral blood absolute lymphocyte count of >5,000/mm3 obtained within 2 weeks prior to start of study The lymphocytosis must consist of small, mature lymphocytes,... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-21.0, Diffuse Large B Cell Lymphoma Post Transplant Lymphoproliferative Disorder Primary Mediastinal (Thymic) Large B-cell Lymphoma Patient with newly diagnosed, histologically confirmed, Group B or C diffuse large B-cell lymphoma; or primary mediastinal B-cell lymphoma. Patients with Group ... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hepatocellular Cancer Histologically confirmed advanced HCC Barcelona Clinic Liver Cancer stage C or stage B if you cannot tolerate or failed TACE No cirrhosis or Child-Pugh A cirrhosis Measurable lesions All acute toxic effects of any prior treatment have resolved to NCI-CTCAE v4.0 ... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Waldenstrom Macroglobulinemia Histologically confirmed diagnosis of WM At least one prior systemic therapy Measurable disease, defined as quantifiable monoclonal IgM > 1000 mg/dL Active disease requiring therapy defined as at least one of the following five 1. Rising IgM 2. Hemoglobi... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 16.0-65.0, Germ Cell Tumour Germ Cell Tumour (GCT) Relapsed or progression on or following platinum-based chemotherapy (rising tumour markers or progressive disease on PET CT Scan prior to entering study) Neutrophil count >1.0x109/l Platelets >70x109/l Haemoglobin >100g/l (may be transfused) Glo... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hyper-reactive Malarial Splenomegaly Malaria Anaemia Defining features of HMS including chronic massive splenomegaly (at least 10 cm below the costal margin); serum Immunoglobulin M elevated more than 3.1 g/L and high malarial antibody titres (above 640) Evidence of the polyclonal na... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 0.0-75.0, Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Acute Lymphocytic Leukemia Referred patients (or respective donors) will initially be consented for procurement of blood for generation of the transduced ATL. at this stage Diagnosis of recurrent B-cell lymphoma or leukemia (ALL or CLL)... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, B-cell Non-Hodgkin Lymphoma Participants with CD20-expressing B-cell NHL that is relapsed or refractory to standard therapy. Chronic lymphocytic leukemia/small lymphocytic lymphoma with peripheral blood leukemia/lymphoma cells and high-grade lymphomas are excluded. 2. Participants mu... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-70.0, Cirrhosis Hepatic Encephalopathy Ambulatory patient with cirrhosis Able to provide informed consent History of alcohol abuse within six months Active gastrointestinal bleeding Unable to provide informed consent | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 65.0-999.0, Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Patients must be diagnosed with CLL in accordance with International Workshop on Chronic Lymphocytic Leukemia (IWCLL) 2008 that incl... | 1 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Hypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET) Any patients who have had PET showing one or more hypermetabolic lymphadenopathy in middle mediastinum and/or lower and/or posterior, and requiring diagnostic certainty for s... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Multiple Organ Failure Age ≥18 years Admitted to emergency department, Karlstad Central Hospital, Sweden Not in need of venous blood sample | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-999.0, Non-Hodgkin Lymphoma Age ≥ 18 years. 2. Diagnosis of relapsed or refractory to previous therapy biopsy-proven Diffuse Large B cell non-Hodgkin's Lymphoma (there is no limit on the number of prior therapies. Subjects who have relapsed following an autologous stem cell transplant are e... | 0 |
This is a 57-year-old gentleman with CLL and large cell transformation. He presented with his disease back in [**10/2119**] with an elevated white count and LDH. He was without any splenomegaly or any cytopenias at that time. He did have some bulky lymphadenopathy. He then completed four cycles of FCR therapy, which he... | eligible ages (years): 18.0-65.0, Rhinitis, Allergic, Perennial and Seasonal Diagnosis of Allergic Rhinitis (AR), as determined by the presence of seasonal or perennial rhinitis symptoms for several months per year, for more than 1 year and are not attributed to infections or nasal abnormalities Subjects have a TNSS s... | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.